论文信息 - Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial - 字舞流文

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

M. Kudo | R. Finn | J. Jassem | F. Piscaglia | Joong-Won Park | A. Cheng | G. Han | A. Vogel | Kenichi Saito | J. Blanc | A. Baron | T. Evans | S. Qin | K. Ikeda | K. Han | M. Ren | C. Dutcus | C. Lopez | T. Tamai | D. Komov | M. Guo | S. Kraljevic | Richard Finn | Jean Frederic Blanc | TR Jeffry Evans | Jean Frederic Blanc | T. J. Evans | Jean Frédéric Blanc | J. Blanc